MorphoSys (MOR) SEC Filings & 10K Form

$19.00
-0.34 (-1.76%)
(As of 05/17/2024 ET)

Recent MorphoSys SEC Filings

DateFilerForm TypeView
05/17/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/16/2024
3:43 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
05/16/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/16/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
9:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/13/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2024
9:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
3:45 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/07/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/06/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
05/02/2024
9:43 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
7:57 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
3:15 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/25/2024
9:38 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
10:03 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
9:14 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
9:32 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/19/2024
9:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2024
3:31 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/18/2024
1:33 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC 13D
04/18/2024
9:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
3:49 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9/A
04/17/2024
3:30 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
4:07 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/16/2024
9:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/15/2024
2:44 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T/A
04/12/2024
9:54 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
10:57 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 14D9
04/11/2024
5:01 AM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-T
04/09/2024
9:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/04/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Elon to Transform U.S. Economy? (Ad)

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.
04/02/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2024
12:16 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2024
10:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2024
10:37 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
10:17 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
5:47 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2024
10:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
3:12 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
10:13 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2024
10:10 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2024
10:23 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/15/2024
3:46 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
03/15/2024
10:18 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
3:52 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
03/14/2024
10:10 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
7:27 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
4:22 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
03/13/2024
3:07 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/13/2024
3:08 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
3:12 PM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2024
10:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
3:36 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G
03/11/2024
10:07 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
6:05 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/08/2024
2:58 PM
Kynam Capital Management, LP (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G/A
03/08/2024
9:06 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
11:33 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2024
9:15 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/29/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
9:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2024
9:11 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/23/2024
9:37 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2024
9:24 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:19 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/16/2024
10:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
9:31 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
11:47 AM
Kynam Capital Management, LP (Filed by)
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC 13G
02/14/2024
9:42 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/13/2024
9:08 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
9:29 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/09/2024
9:21 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/08/2024
9:18 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
4:19 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
02/07/2024
9:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
5:57 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Did you know you can now trade Bitcoin in your regular brokerage account? (Ad)

You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet!

>> Tap here to sign up and join them for the imminent workshop
02/06/2024
3:58 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
02/06/2024
3:52 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-C
02/06/2024
9:45 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/05/2024
4:06 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
NOVARTIS AG (Filed by)
Form SC TO-C
02/05/2024
4:11 PM
MorphoSys (Subject)
MorphoSys AG (Subject)
Form SC14D9C
02/05/2024
9:09 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/02/2024
9:10 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2024
9:10 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
9:12 AM
MorphoSys (Filer)
MorphoSys AG (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:MOR) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners